MedPath

K Study of magnetic resonance imaging (MRI) for breast screening

Phase 3
Completed
Conditions
Cancer
Topic: National Cancer Research Network
Subtopic: Breast Cancer
Disease: Breast
Breast Cancer
Registration Number
ISRCTN30587563
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
900
Inclusion Criteria

Group 1:
1. Women aged 35 - 49 years
2. Tested BRCA1 or BRCA2 carriers
3. Known mutation in first degree relative
4. Family history of breast and ovarian cancer (four or more relatives)

Group 2:
1. Women aged 25 - 49 years
2. Tested p53 carriers
3. Known mutation in a first degree relative
4. Family history consistent with Li Frameni syndrome

Exclusion Criteria

1. Previous breast cancer (including ductal carcinoma in situ [DCIS])
2. Terminal illness, or life expectancy of less than 5 years
3. Pregnancy or breast-feeding (recruitment suspended until breast-feeding has finished)
4. Current chemotherapy (recruitment suspended until 6 months after treatment ceases; exclusion 2, above, still applies)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Annual MRI and x-ray breast examination
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath